Department of Chemistry, Radiochemistry Laboratory, St. Petersburg State University, St. Petersburg 199034, Russia.
J Mol Model. 2013 Apr;19(4):1819-34. doi: 10.1007/s00894-012-1745-0. Epub 2013 Jan 15.
DFT (B3LYP and M06L) as well as ab initio (MP2) methods with Dunning cc-pVnZ (n=2,3) basis sets are employed for the study of the binding ability of the new class of protease inhibitors, i.e., silanediols, in comparison to the well-known and well-studied class of inhibitors with hydroxamic functionality (HAM). Active sites of metalloproteases are modeled by [R₃M-OH₂]²⁺ complexes, where R stands for ammonia or imidazole molecules and M is a divalent cation, namely zinc, iron or nickel (in their different spin states). The inhibiting activity is estimated by calculating Gibbs free energies of the water displacement by metal binding groups (MBGs) according to: [R₃M-OH₂]²⁺ + MBG → [R₃M-MBG]²⁺ + H₂O. The binding energy of silanediol is only a few kcal mol(-1) inferior to that of HAM for zinc and iron complexes and is even slightly higher for the triplet state of the (NH₃)₃Ni²⁺ complex. For both MBGs studied in the ammonia model the binding ability is nearly the same, i.e., Fe²⁺(t) > Ni²⁺(t) > Fe²⁺(q) > Ni²⁺(s) > Zn²⁺. However, for the imidazole model the order is slightly different, i.e., Ni²⁺(t) > Fe²⁺(t) > Fe²⁺(q) > Ni²⁺(s) ≥ Zn²⁺. Equilibrium structures of the R₃Zn ²⁺ complexes with both HAM and silanediol are characterized by the monodentate binding, but the bidentate character of binding increases on going to iron and nickel complexes. Two types of intermediates of the water displacement reactions for [(NH₃)₃M-OH₂]²⁺ complexes were found which differ by the direction of the attack of the MBG. Hexacoordinated complexes exhibit bidentate bonding of MBGs and are lower in energy for M=Ni and Fe. For Zn penta- and hexacoordinated complexes have nearly the same energy. Intermediate complexes with imidazole ligands have only octahedral structures with bidentate bonding of both HAM and dimethylsilanediol molecules.
采用 DFT(B3LYP 和 M06L)以及从头算(MP2)方法,结合 Dunning cc-pVnZ(n=2,3)基组,研究了新型蛋白酶抑制剂硅烷二醇与众所周知且研究充分的具有偕氨肟官能团(HAM)的抑制剂类别的结合能力。金属蛋白酶的活性部位通过 [R₃M-OH₂]²⁺ 配合物建模,其中 R 代表氨或咪唑分子,M 是二价阳离子,即锌、铁或镍(处于不同的自旋态)。根据以下公式计算金属结合基团(MBG)取代水的吉布斯自由能来估计抑制活性:[R₃M-OH₂]²⁺ + MBG → [R₃M-MBG]²⁺ + H₂O。硅烷二醇与锌和铁配合物的结合能仅比 HAM 低几个千卡每摩尔(kcal/mol),并且对于(NH₃)₃Ni²⁺ 配合物的三重态甚至略高。对于在氨模型中研究的两种 MBG,结合能力几乎相同,即 Fe²⁺(t) > Ni²⁺(t) > Fe²⁺(q) > Ni²⁺(s) > Zn²⁺。然而,对于咪唑模型,顺序略有不同,即 Ni²⁺(t) > Fe²⁺(t) > Fe²⁺(q) > Ni²⁺(s) ≥ Zn²⁺。具有 HAM 和硅烷二醇的 R₃Zn ²⁺ 配合物的平衡结构具有单齿配位的特征,但结合的双齿特征随着铁和镍配合物的增加而增加。发现了 [(NH₃)₃M-OH₂]²⁺ 配合物的水取代反应的两种中间体,它们的区别在于 MBG 的攻击方向。六配位配合物表现出 MBG 的双齿键合,对于 M=Ni 和 Fe,能量较低。对于 Zn,五配位和六配位配合物的能量几乎相同。具有咪唑配体的中间体仅具有八面体结构,偕氨肟和二甲基硅烷二醇分子均具有双齿键合。